Exhibit 99.3

ASML — Summary U.S. GAAP Consolidated Statements of Operations ¹


	Three months ended,					Six months ended,
(in thousands EUR, except per share data)	Jun 29, 2008		Jun 28, 2009			Jun 29, 2008			Jun 28, 2009


Net system sales		725,586		183,259			1,545,572			284,359
Net service and field option sales		118,571		93,341			217,793			175,866

Total net sales		844,157		276,600			1,763,365			460,225

Cost of sales		506,689		242,162			1,052,271			413,425

Gross profit on sales		337,468		34,438			711,094			46,800

Research and development costs, net of credits		130,241		117,890			258,500			236,205
Selling, general and administrative costs		56,368		40,978			113,695			81,973

Income (loss) from operations		150,859		(124,430	)		338,899			(271,378	)

Interest income (expense)		6,372		(238	)		10,573			(1,269	)

Income (loss) from operations before income taxes		157,231		(124,668	)		349,472			(272,647	)

(Provision for) benefit from income taxes		34,746		20,715			(12,372	)		51,503

Net income (loss)		191,977		(103,953	)		337,100			(221,144	)

Basic net income (loss) per ordinary share		0.45		(0.24	)		0.78			(0.51	)
Diluted net income (loss) per ordinary share ²		0.44		(0.24	)		0.78			(0.51	)

Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,221		432,454			431,412			432,283
Diluted ²		434,585		432,454			434,819			432,283

ASML — Ratios and Other Data ¹


	Three months ended,					Six months ended,
	Jun 29, 2008		Jun 28, 2009			Jun 29, 2008			Jun 28, 2009


Gross profit as a % of net sales		40.0		12.5			40.3			10.2
Income (loss) from operations as a % of net sales		17.9		(45.0	)		19.2			(59.0	)
Net income (loss) as a % of net sales		22.7		(37.6	)		19.1			(48.1	)
Shareholders’ equity as a % of total assets		49.7		47.7			49.7			47.7
Income taxes as a % of income before income taxes		22.1		(16.6	)		(3.5	)		(18.9	)
Sales of systems (in units)		39		10			89			21
ASP of systems sales (EUR million)		18.6		18.3			17.4			13.5
Value of backlog systems (EUR million)		1,106		1,064			1,106			1,064
Backlog systems (in units)		59		43			59			43
ASP of backlog systems (EUR million)		18.8		24.7			18.8			24.7
Value of booked systems (EUR million)		632		394			944			601
Net bookings (in units)		33		15			59			23
ASP of booked systems (EUR million)		19.2		26.3			16.0			26.1
Number of payroll employees in FTEs		6,821		6,597			6,821			6,597
Number of temporary employees in FTEs		1,649		868			1,649			868

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹


(in thousands EUR)	Dec 31, 2008		Jun 28, 2009


ASSETS

Cash and cash equivalents		1,109,184		1,092,660
Accounts receivable, net		463,273		213,532
Finance receivables, net		6,225		52
Current tax assets		87,560		—
Inventories, net		999,150		926,080
Deferred tax assets		71,780		70,486
Other assets		236,077		220,258

Total current assets		2,973,249		2,523,068

Finance receivables, net		31,030		20,609
Deferred tax assets		148,133		198,867
Other assets		88,197		53,764
Goodwill		131,453		134,536
Other intangible assets, net		26,692		22,300
Property, plant and equipment, net		540,640		591,917

Total non-current assets		966,145		1,021,993

Total assets		3,939,394		3,545,061

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,008,343		940,918
Long-term debt		647,050		651,917
Deferred and other tax liabilities		209,699		200,578
Provisions		15,495		14,790
Accrued liabilities and other liabilities		70,038		45,618

Total non-current liabilities		942,282		912,903


Total liabilities		1,950,625		1,853,821

Shareholders’ equity		1,988,769		1,691,240

Total liabilities and shareholders’ equity		3,939,394		3,545,061

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹


	Three months ended,						Six months ended,
(in thousands EUR)	Jun 29, 2008			Jun 28, 2009			Jun 29, 2008			Jun 28, 2009


CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss)		191,977			(103,953	)		337,100			(221,144	)

Depreciation and amortization		26,452			31,660			55,477			69,536
Impairment		93			4,387			1,644			6,979
Loss on disposals of property, plant and equipment		1,311			8,699			2,414			11,338
Share-based payments		3,109			2,581			6,676			6,093
Allowance for doubtful debts		(647	)		1,177			(107	)		1,164
Allowance for obsolete inventory		11,790			43,897			32,556			66,032
Deferred income taxes		(54,457	)		(31,211	)		(33,868	)		(58,234	)
Change in assets and liabilities		(49,651	)		113,798			(4,563	)		271,512

Net cash provided by operating activities		129,977			71,035			397,329			153,276

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment		(65,441	)		(43,336	)		(120,473	)		(87,240	)
Proceeds from sale of property, plant and equipment		—			—			—			1,200

Net cash used in investing activities		(65,441	)		(43,336	)		(120,473	)		(86,040	)

CASH FLOWS FROM FINANCING ACTIVITIES

Dividend paid		(107,447	)		(86,486	)		(107,447	)		(86,486	)
Purchase of shares in conjunction with share-based payment plans		—			—			(87,605	)		—
Net proceeds from issuance of shares and stock options		552			429			3,527			532
Excess tax benefits from stock options		5,969			469			5,973			248
Net proceeds from other long-term debt		—			32			—			32
Redemption and/or repayment of debt		—			(9	)		—			(9	)

Net cash used in financing activities		(100,926	)		(85,565	)		(185,552	)		(85,683	)


Net cash flows		(36,390	)		(57,866	)		91,304			(18,447	)

Effect of changes in exchange rates on cash		144			(484	)		(2,042	)		1,923

Net increase (decrease) in cash & cash equivalents		(36,246	)		(58,350	)		89,262			(16,524	)

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations ¹


	Three months ended,
	Jun 29,		Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in millions EUR, except per share data)	2008		2008			2008			2009			2009


Net system sales		725.6		590.7			380.5			101.1			183.3
Net service and field option sales		118.6		105.8			113.3			82.5			93.3

Total net sales		844.2		696.5			493.8			183.6			276.6

Cost of sales		506.7		431.1			454.8			171.2			242.2

Gross profit on sales		337.5		265.4			39.0			12.4			34.4

Research and development costs, net of credits		130.2		130.2			127.5			118.3			117.9
Selling, general and administrative costs		56.4		51.9			46.7			41.0			41.0

Income (loss) from operations		150.9		83.3			(135.2	)		(146.9	)		(124.5	)

Interest income (expense)		6.4		7.1			5.0			(1.1	)		(0.2	)

Income (loss) from operations before income taxes		157.3		90.4			(130.2	)		(148.0	)		(124.7	)

(Provision for) benefit from income taxes		34.7		(17.1	)		42.2			30.8			20.7

Net income (loss)		192.0		73.3			(88.0	)		(117.2	)		(104.0	)

Basic net income (loss) per ordinary share		0.45		0.17			(0.20	)		(0.27	)		(0.24	)
Diluted net income (loss) per ordinary share ²		0.44		0.17			(0.20	)		(0.27	)		(0.24	)

Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,221		431,672			431,989			432,112			432,454
Diluted ²		434,585		434,491			431,989			432,112			432,454

ASML — Quarterly Summary Ratios and other data ¹


	Three months ended,
	Jun 29,		Sep 28,			Dec 31,			Mar 29,			Jun 28,
	2008		2008			2008			2009			2009


Gross profit as a % of net sales		40.0		38.1			7.9			6.7			12.5
Income (loss) from operations as a % of net sales		17.9		12.0			(27.4	)		(80.0	)		(45.0	)
Net income (loss) as a % of net sales		22.7		10.5			(17.8	)		(63.8	)		(37.6	)
Shareholders’ equity as a % of total assets		49.7		50.3			50.5			48.0			47.7
Income taxes as a % of income before income taxes		22.1		(18.9	)		(32.4	)		(20.8	)		(16.6	)
Sales of systems (in units)		39		37			25			11			10
ASP of system sales (EUR million)		18.6		16.0			15.2			9.2			18.3
Value of backlog systems (EUR million)		1,106		1,028			755			853			1,064
Backlog systems (in units)		59		53			41			38			43
ASP of backlog systems (EUR million)		18.8		19.4			18.4			22.4			24.7
Value of booked systems (EUR million)		632		498			127			207			394
Net bookings (in units)		33		31			13			8			15
ASP of booked systems (EUR million)		19.2		16.1			9.8			25.8			26.3
Number of payroll employees in FTEs		6,821		6,907			6,930			6,715			6,597
Number of temporary employees in FTEs		1,649		1,610			1,329			959			868

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹


	Jun 29,		Sep 28,		Dec 31,		Mar 29,		Jun 28,
(in millions EUR)	2008		2008		2008		2009		2009


ASSETS
Cash and cash equivalents		1,360.9		1,313.0		1,109.2		1,151.0		1,092.7
Accounts receivable, net		516.7		536.1		463.3		291.6		213.5
Finance receivables, net		0.2		7.4		6.2		6.2		0.1
Current tax assets		—		—		87.6		—		—
Inventories, net		1,130.2		1,134.0		999.1		936.8		926.1
Deferred tax assets		69.8		82.8		71.8		74.9		70.5
Other assets		262.2		261.4		236.1		240.6		220.2

Total current assets		3,340.0		3,334.7		2,973.3		2,701.1		2,523.1

Finance receivables, net		—		30.7		31.0		29.2		20.6
Deferred tax assets		157.7		139.4		148.1		173.2		198.9
Other assets		39.3		50.6		88.2		89.5		53.8
Goodwill		119.8		129.2		131.5		139.7		134.5
Other intangible assets, net		30.1		28.8		26.7		25.6		22.3
Property, plant and equipment, net		458.1		503.1		540.6		586.6		591.9

Total non-current assets		805.0		881.8		966.1		1,043.8		1,022.0

Total assets		4,145.0		4,216.5		3,939.4		3,744.9		3,545.1

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,247.3		1,273.0		1,008.3		1,017.5		940.9
Long-term debt		591.6		596.7		647.1		661.4		651.9
Deferred and other tax liabilities		227.0		215.2		209.7		204.9		200.6
Provisions		—		—		15.5		16.9		14.8
Accrued liabilities and other liabilities		18.5		8.8		70.0		48.2		45.6

Total non-current liabilities		837.1		820.7		942.3		931.4		912.9


Total liabilities		2,084.4		2,093.7		1,950.6		1,948.9		1,853.8

Shareholders’ equity		2,060.6		2,122.8		1,988.8		1,796.0		1,691.3

Total liabilities and shareholders’ equity		4,145.0		4,216.5		3,939.4		3,744.9		3,545.1

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹


	Three months ended,
	Jun 29,			Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in millions EUR)	2008			2008			2008			2009			2009


CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		192.0			73.3			(88.0	)		(117.2	)		(104.0	)

Depreciation and amortization		26.5			28.6			35.1			37.9			31.6
Impairment		0.1			0.6			22.9			2.6			4.4
Loss on disposals of property, plant and equipment		1.3			1.4			0.4			2.6			8.7
Share-based payments		3.1			3.7			3.2			3.5			2.6
Allowance for doubtful debts		(0.6	)		(0.2	)		0.5			—			1.2
Allowance for obsolete inventory		11.8			21.3			85.8			22.1			43.9
Deferred income taxes		(54.5	)		2.4			(2.7	)		(27.0	)		(31.2	)
Change in assets and liabilities		(49.7	)		(110.2	)		(194.6	)		157.7			113.8

Net cash provided by (used in) operating activities		130.0			20.9			(137.4	)		82.2			71.0

CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(65.5	)		(68.3	)		(71.1	)		(43.9	)		(43.3	)
Proceeds from sale of property, plant and equipment		—			—			—			1.2			—

Net cash used in investing activities		(65.5	)		(68.3	)		(71.1	)		(42.7	)		(43.3	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(107.4	)		(0.4	)		—			—			(86.5	)
Net proceeds from issuance of shares and stock options		0.5			1.4			6.5			0.1			0.4
Excess tax benefits (deficiencies) from stock options		6.0			(1.9	)		(1.9	)		(0.2	)		0.5
Net proceeds from other long-term debt		—			—			—			—			0.1
Redemption and/or repayment of debt		—			(1.3	)		(1.1	)		—			—

Net cash provided by (used in) financing activities		(100.9	)		(2.2	)		3.5			(0.1	)		(85.5	)


Net cash flows		(36.4	)		(49.6	)		(205.0	)		39.4			(57.8	)

Effect of changes in exchange rates on cash		0.2			1.7			1.2			2.4			(0.5	)

Net increase (decrease) in cash & cash equivalents		(36.2	)		(47.9	)		(203.8	)		41.8			(58.3	)

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as sales transactions, forecasted purchase transactions and accounts receivable/accounts payable. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of June 28, 2009 EUR 36.9 million loss of other comprehensive income, net of taxes, represents the total anticipated loss to be charged to net sales, and EUR 1.2 million gain represents the total anticipated gain to be released to cost of sales when the forecasted revenue and purchase transactions occur.

ASML — Reconciliation U.S. GAAP — IFRS ¹

Net income


	Three months ended,						Six months ended,
(in thousands EUR)	Jun 29, 2008			Jun 28, 2009			Jun 29, 2008			Jun 28, 2009

Net income (loss) under U.S. GAAP		191,977			(103,953	)		337,100			(221,144	)
Share-based payments (see Note 1)		245			1,396			(518	)		897
Capitalization of development costs (see Note 2)		18,649			21,760			40,330			33,275
Income taxes (see Note 3)		(380	)		(458	)		39			(2,058	)

Net income (loss) under IFRS		210,491			(81,255	)		376,951			(189,030	)

Shareholders’ equity


	Jun 29,			Sep 28,			Dec 31,			Mar 29,			Jun 28,
(in thousands EUR)	2008			2008			2008			2009			2009

Shareholders’ equity under U.S. GAAP		2,060,575			2,122,848			1,988,769			1,795,951			1,691,240
Share-based payments (see Note 1)		(3,266	)		(7,904	)		(6,537	)		(7,088	)		(4,918	)
Capitalization of development costs (see Note 2)		176,818			193,780			201,717			215,452			235,945
Income taxes (see Note 3)		8,478			5,969			4,794			3,361			2,797

Shareholders’ equity under IFRS		2,242,605			2,314,693			2,188,743			2,007,676			1,925,064

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRSs, a deferred tax asset is computed on the basis of the tax deduction for the share-based payments every period under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. SFAS 123(R)’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.

Statutory Interim Report

On July 24, 2009 ASML will publish its Statutory Interim Report for the six months period ended June 28, 2009. This report is in accordance with the requirements of the EU Transparency Directive and will include an Interim Management Board Report, a Managing Directors’ Statement and Consolidated Condensed Interim Financial Statements in accordance with IAS 34, “Interim Financial Reporting”. The EU Transparency Directive is applicable for all listed companies as of January 1, 2009. The Statutory Interim Report for the six months period ended June 28, 2009 will be available online at www.asml.com.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.


¹		All quarterly information in this press release is unaudited.

²		The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.